Theriva Biologics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MSD PARTNERS, L.P. | 08/14/2024 | 598.41 K | $141.41 K | 100.00% | 3.49% |
| VANGUARD GROUP INC | 08/13/2024 | 194.49 K | $45.96 K | -13.66% | 1.13% |
| BLACKROCK INC. | 08/13/2024 | 189.18 K | $44.70 K | 0.00% | 1.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 141.17 K | $33.37 K | 0.00% | 0.82% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 103.71 K | $24.51 K | 51.38% | 0.60% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 61.02 K | $14.42 K | 186.86% | 0.36% |
| STATE STREET CORP | 08/14/2024 | 48.69 K | $11.51 K | 0.00% | 0.28% |
| NORTHERN TRUST CORP | 08/14/2024 | 26.48 K | $6.26 K | -0.46% | 0.15% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 11.05 K | $2.61 K | 23,404.26% | 0.06% |
| SAGEVIEW ADVISORY GROUP, LLC | 08/12/2024 | 10.43 K | $1.00 M | 0.00% | 0.06% |
| BLAIR WILLIAM & CO/IL | 08/12/2024 | 10.15 K | $2.40 K | 0.00% | 0.06% |
| FMR LLC | 08/13/2024 | 500 | $118 | 4,900.00% | 0.00% |
| IRON HORSE WEALTH MANAGEMENT, LLC | 07/22/2024 | 365 | $86 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 07/30/2024 | 296 | $70 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 146 | $34 | 2,333.33% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 145 | $34 | 0.00% | 0.00% |
| PLANNING CAPITAL MANAGEMENT CORP | 08/12/2024 | 110 | $26 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 100 | $24 | -57.08% | 0.00% |
| OLD POINT TRUST & FINANCIAL SERVICES N A | 08/13/2024 | 100 | $24 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 14 | $3 | 0.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 3 | $1 | 0.00% | 0.00% |
| LINCOLN NATIONAL CORP | 07/25/2024 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Theriva Biologics, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Theriva Biologics, Inc.. The most heavily invested institutionals were:
Planning Capital Management Corp: 0
BlackRock Inc.: 189,181
8.14% of Theriva Biologics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 189.18 K shares in the last 24 months. This purchase volume represents approximately $43.51 K in transactions.